Showing results (241-250 of 316) with videos related to
Sort By:
Pageof 32
Journal for Immunotherapy of Cancer|October 27, 2022
Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor typesJake G Maule, Lani K Clinton, Ryon P Graf, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2018
The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanomaN P Graf, P Koelblinger, N Galliker, et al.International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|December 1, 1993
HIV-1 infection as a risk factor for leprosy; a case-control study in TanzaniaM W Borgdorff, J van den Broek, H J Chum, et al.Plos Pathogens|April 20, 2026
Combining pangenomics and population genetics finds chromosomal re-arrangements, diversified chromosome segments, copy number variations and transposon polymorphisms in wheat and rye powdery mildewAlexandros G Sotiropoulos, Marion C Müller, Lukas Kunz, et al.Cancer Research Communications|March 16, 2023
Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal CancerRyon P Graf, Virginia Fisher, James Creeden, et al.Journal of Circulating Biomarkers|September 23, 2017
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and CharacterizationShannon L Werner, Ryon P Graf, Mark Landers, et al.The Oncologist|June 23, 2025
Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancerGerald Li, Stephanie B Greene, Baljinder Kaur, et al.European Urology Open Science|September 4, 2023
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate CancerHelen Y Hougen, Ryon P Graf, Gerald Li, et al.Biorxiv : the Preprint Server for Biology|March 18, 2024
A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine AdjuvantErin M Euliano, Brett H Pogostin, Anushka Agrawal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2025
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized TrialAndrew J Armstrong, Hilary Dietz, David Balli, et al.Pageof 32